Moisture lesions, specifically incontinence-associated dermatitis (IAD) also known as a moisture lesion, continue to present a significant health challenge and require a multidisciplinary approach to provide effective prevention and treatment care pathway. This evaluation reports on 20 patients in a community and rehabilitation unit following the local IAD care pathway with use of CD Medical’s Clinifilm® spray or Clinifilm® barrier cream on incidents of incontinence. All patient had IAD at the start the evaluation. The number days it took patients’ incontinence-associated dermatitis to resolve varied from 3–10 days (mean 5 days). The patient skin integrity was regained back to normal. The number of days the patients remained on the audit ranged from 7 to 30 days (mean 20 days). The author suggests that a larger evaluation of the products is necessary to gain statistical significance, but Clinifilm® spray and Clinifilm® barrier cream provide effective management of IAD and can be resolved with good patient outcomes in this vulnerable client group.